Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS)
CNY 25.83
(0.16%)
CNY 25.83
(0.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.61 Billion CNY | 11.3% |
| 2022 | 2.85 Billion CNY | 25.28% |
| 2021 | 2.28 Billion CNY | 27.01% |
| 2020 | 1.8 Billion CNY | -16.51% |
| 2019 | 2.15 Billion CNY | -1.81% |
| 2018 | 2.18 Billion CNY | 36.41% |
| 2017 | 1.59 Billion CNY | 32.04% |
| 2016 | 1.2 Billion CNY | 32.02% |
| 2015 | 919.19 Million CNY | 31.94% |
| 2014 | 694.74 Million CNY | 27.59% |
| 2013 | 543.72 Million CNY | 4363.35% |
| 2012 | 12.29 Million CNY | -72.06% |
| 2011 | 46.01 Million CNY | 3.39% |
| 2010 | 41.29 Million CNY | 5.66% |
| 2009 | 37.04 Million CNY | 2.49% |
| 2008 | 37.76 Million CNY | -16.14% |
| 2007 | 43.16 Million CNY | 20.75% |
| 2006 | 38.79 Million CNY | 13.79% |
| 2005 | 34.04 Million CNY | 15.86% |
| 2004 | 29.36 Million CNY | 18.66% |
| 2003 | 24.8 Million CNY | -24.89% |
| 2002 | 33.01 Million CNY | 11.18% |
| 2001 | 29.69 Million CNY | -3.72% |
| 2000 | 30.84 Million CNY | 95.05% |
| 1999 | 15.81 Million CNY | 75.5% |
| 1998 | 9.01 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 508.92 Million CNY | -38.3% |
| 2024 Q1 | 939.63 Million CNY | -3.91% |
| 2024 Q3 | 672.7 Million CNY | 1.55% |
| 2023 Q1 | 746.47 Million CNY | 5.35% |
| 2023 FY | - CNY | 11.3% |
| 2023 Q4 | 1 Billion CNY | 47.39% |
| 2023 Q3 | 683.7 Million CNY | -12.47% |
| 2023 Q2 | 781.12 Million CNY | 4.64% |
| 2022 Q4 | 708.58 Million CNY | 6.81% |
| 2022 Q2 | 517.13 Million CNY | -22.44% |
| 2022 Q1 | 666.79 Million CNY | 24.55% |
| 2022 FY | - CNY | 25.28% |
| 2022 Q3 | 663.42 Million CNY | 28.29% |
| 2021 Q2 | 509.81 Million CNY | 2.57% |
| 2021 Q1 | 497.04 Million CNY | 24.49% |
| 2021 Q4 | 535.35 Million CNY | 18.82% |
| 2021 Q3 | 450.57 Million CNY | -11.62% |
| 2021 FY | - CNY | 27.01% |
| 2020 Q4 | 399.27 Million CNY | 23.2% |
| 2020 FY | - CNY | -16.51% |
| 2020 Q2 | 239.57 Million CNY | -56.95% |
| 2020 Q3 | 324.09 Million CNY | 35.28% |
| 2020 Q1 | 556.48 Million CNY | 41.4% |
| 2019 Q4 | 393.55 Million CNY | 1.97% |
| 2019 Q1 | 621.52 Million CNY | 41.16% |
| 2019 Q2 | 522.84 Million CNY | -15.88% |
| 2019 Q3 | 385.94 Million CNY | -26.18% |
| 2019 FY | - CNY | -1.81% |
| 2018 Q2 | 462.84 Million CNY | -17.66% |
| 2018 Q4 | 440.3 Million CNY | -20.7% |
| 2018 FY | - CNY | 36.41% |
| 2018 Q1 | 562.14 Million CNY | 27.0% |
| 2018 Q3 | 555.23 Million CNY | 19.96% |
| 2017 Q2 | 381.5 Million CNY | 21.16% |
| 2017 Q1 | 314.87 Million CNY | -3.92% |
| 2017 FY | - CNY | 32.04% |
| 2017 Q4 | 442.62 Million CNY | 25.4% |
| 2017 Q3 | 352.97 Million CNY | -7.48% |
| 2016 Q4 | 327.72 Million CNY | 22.56% |
| 2016 FY | - CNY | 32.02% |
| 2016 Q1 | 234.91 Million CNY | -10.02% |
| 2016 Q3 | 267.39 Million CNY | -8.11% |
| 2016 Q2 | 290.99 Million CNY | 23.87% |
| 2015 Q4 | 261.06 Million CNY | 44.35% |
| 2015 FY | - CNY | 31.94% |
| 2015 Q2 | 230.65 Million CNY | 37.31% |
| 2015 Q3 | 180.86 Million CNY | -21.59% |
| 2015 Q1 | 167.97 Million CNY | -18.34% |
| 2014 Q2 | 181.06 Million CNY | 44.53% |
| 2014 Q3 | 129.52 Million CNY | -28.46% |
| 2014 Q4 | 205.7 Million CNY | 58.81% |
| 2014 FY | - CNY | 27.59% |
| 2014 Q1 | 125.27 Million CNY | -75.09% |
| 2013 Q4 | 502.86 Million CNY | 3916.27% |
| 2013 FY | - CNY | 4363.35% |
| 2013 Q2 | -13.62 Million CNY | -495.13% |
| 2013 Q1 | 3.44 Million CNY | 109.96% |
| 2013 Q3 | -13.17 Million CNY | 3.32% |
| 2012 Q3 | 3.58 Million CNY | -7.88% |
| 2012 Q1 | 4.6 Million CNY | 2067.35% |
| 2012 Q2 | 3.89 Million CNY | -15.56% |
| 2012 FY | - CNY | -72.06% |
| 2012 Q4 | -34.63 Million CNY | -1065.86% |
| 2011 FY | - CNY | 3.39% |
| 2011 Q1 | 3.95 Million CNY | 17.83% |
| 2011 Q2 | 5.37 Million CNY | 35.98% |
| 2011 Q3 | 8.73 Million CNY | 62.36% |
| 2011 Q4 | -234.31 Thousand CNY | -102.68% |
| 2010 Q2 | 8.06 Million CNY | 143.13% |
| 2010 FY | - CNY | 5.66% |
| 2010 Q4 | 3.35 Million CNY | -43.49% |
| 2010 Q3 | 5.93 Million CNY | -26.37% |
| 2010 Q1 | 3.31 Million CNY | -48.29% |
| 2009 Q1 | 3.44 Million CNY | -51.81% |
| 2009 FY | - CNY | 2.49% |
| 2009 Q4 | 6.41 Million CNY | 9.63% |
| 2009 Q3 | 5.85 Million CNY | -10.95% |
| 2009 Q2 | 6.57 Million CNY | 90.69% |
| 2008 Q1 | 2.61 Million CNY | -75.9% |
| 2008 Q3 | 3.85 Million CNY | -40.7% |
| 2008 FY | - CNY | -16.14% |
| 2008 Q4 | 7.15 Million CNY | 85.67% |
| 2008 Q2 | 6.49 Million CNY | 148.75% |
| 2007 Q3 | 3.85 Million CNY | -63.39% |
| 2007 Q2 | 10.53 Million CNY | 500.73% |
| 2007 Q1 | 1.75 Million CNY | -88.84% |
| 2007 FY | - CNY | 20.75% |
| 2007 Q4 | 10.83 Million CNY | 180.99% |
| 2006 Q4 | 15.7 Million CNY | 182.74% |
| 2006 Q2 | 16.47 Million CNY | 223.45% |
| 2006 Q1 | 5.09 Million CNY | -59.82% |
| 2006 Q3 | 5.55 Million CNY | -66.27% |
| 2006 FY | - CNY | 13.79% |
| 2005 Q2 | 14.44 Million CNY | 206.59% |
| 2005 Q4 | 12.67 Million CNY | 125.46% |
| 2005 Q3 | 5.62 Million CNY | -61.07% |
| 2005 FY | - CNY | 15.86% |
| 2005 Q1 | 4.7 Million CNY | -52.07% |
| 2004 FY | - CNY | 18.66% |
| 2004 Q1 | 3.73 Million CNY | -14.51% |
| 2004 Q3 | 5.73 Million CNY | -57.34% |
| 2004 Q4 | 9.82 Million CNY | 71.44% |
| 2004 Q2 | 13.43 Million CNY | 259.78% |
| 2003 Q3 | 5.54 Million CNY | -56.07% |
| 2003 FY | - CNY | -24.89% |
| 2003 Q2 | 12.62 Million CNY | 92.75% |
| 2003 Q1 | 6.55 Million CNY | -30.13% |
| 2003 Q4 | 4.36 Million CNY | -21.24% |
| 2002 Q3 | 3.13 Million CNY | -49.7% |
| 2002 Q2 | 6.23 Million CNY | 28.11% |
| 2002 FY | - CNY | 11.18% |
| 2002 Q1 | 4.86 Million CNY | 0.0% |
| 2002 Q4 | 9.37 Million CNY | 198.84% |
| 2001 FY | - CNY | -3.72% |
| 2000 FY | - CNY | 95.05% |
| 1999 FY | - CNY | 75.5% |
| 1998 FY | - CNY | 0.0% |